Hemostasis Today
NewsFeed
Headlines Hematology Health Medicine VTE ASH Plasma Donation
August, 2026
August 2026
M T W T F S S
 12
3456789
10111213141516
17181920212223
24252627282930
31  
Patrick James Lynch: Speaking About the Risks and Benefits of Rebalancing Agents to Treat Hemophilia
Photo: podcasts.apple.com
Apr 29, 2026, 15:01

Patrick James Lynch: Speaking About the Risks and Benefits of Rebalancing Agents to Treat Hemophilia

Patrick James Lynch, the CEO of Believe Limited, shared Global Hemophilia Report‘s post on LinkedIn:

“Thank you, Cedric Hermans, for speaking about the risks and benefits of rebalancing agents to treat hemophilia on the latest episode of the Global Hemophilia Report podcast.

Listen to Dr. Hermans along with Shannon Carpenter, Donna DiMichele, and CJ Hansen discuss the role of rebalancing agents.”

Global Hemophilia Report shared a post on LinkedIn:

“Too much clotting is dangerous.

Too little causes bleeding.

On the latest Global Hemophilia Report, Dr. Cedric Hermans dives into how rebalancing agents strike the delicate middle ground for certain patients -because achieving zero bleeds takes balance.

Guests:

  • Dr. Cedric Hermans, MD, – Hemophilia Centre, Saint-Luc University Hospital, Brussels
  • Dr. Shannon Carpenter, MD – Pediatric Hematology, Kansas City Hemophilia Center:
  • CJ Hansen BSN, RN – Nurse Coordinator and Program Manager, OSU Comprehensive Cancer Center, Patient Advocate

Hosted by: Patrick James Lynch

Listen, Rate, Review, and Subscribe to Global Hemophilia Report where you get your podcasts

Supported through advertising by Sanofi.”

Proceed to the video attached to the post.

Stay updated with Hemostasis Today.

bleeding disorders Cedric Hermans CJ Hansen Donna DiMichele Global Hemophilia Report Health Hematology Hemophilia Hemostasis Hemostasis News Hemostasis Today Medicine Patrick James Lynch Sanofi Shannon Carpenter
NewsFeed